Kozugi et al reported that 18F-FDG PET was an important tool for the detection of port site recurrence of colon cancer in a patient who had elevated serum CEA levels but no metastases detected using routine radiographic examinations [20]. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.